Adage Capital Partners Gp, L.L.C. Aura Biosciences, Inc. Transaction History
Adage Capital Partners Gp, L.L.C.
- $51.6 Billion
- Q1 2025
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Aura Biosciences, Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 4,881,125 shares of AURA stock, worth $33 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
4,881,125
Previous 4,881,125
-0.0%
Holding current value
$33 Million
Previous $40.1 Million
28.71%
% of portfolio
0.06%
Previous 0.07%
Shares
11 transactions
Others Institutions Holding AURA
# of Institutions
95Shares Held
40.3MCall Options Held
6KPut Options Held
6.4K-
Matrix Capital Management Company, LP Waltham, MA6.92MShares$46.9 Million12.68% of portfolio
-
Long Focus Capital Management, LLC San Juan, PR3.32MShares$22.5 Million0.67% of portfolio
-
Medicxi Ventures Management (Jersey) LTD3.04MShares$20.6 Million5.39% of portfolio
-
Black Rock Inc. New York, NY3.01MShares$20.3 Million0.0% of portfolio
-
Suvretta Capital Management, LLC New York, NY2.73MShares$18.5 Million0.7% of portfolio
About Aura Biosciences, Inc.
- Ticker AURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,273,600
- Market Cap $198M
- Description
- Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develop...